MUFFIN STUDY
Patients with a clinically confirmed diagnosis of leg Post-Thrombotic Syndrome (Villalta score ≥ 5) will be randomized for 6 months duration treatment with either Micronized Purified Flavonoid Fraction (Venixxa) or Placebo.
Why are we doing this study?
We want to determine if, in addition to conventional PTS treatment, a 6 month course of oral treatment with Venixxa 500 mg BID is more effective than placebo for the treatment of Post-Thrombotic Syndrome.
Who is eligible?
Patients with leg PTS of Villalta score ≥ 5 with at least two of the following manifestations :
- daily heaviness,
- cramps,
- leg pain,
- edema
What is the study treatment plan?
6 month course of oral treatment with Venixxa or Placebo 500 mg BID for the treatment of Post-Thrombotic Syndrome.
What is involved if I participate in the study?
There are 3 study visits, participants will be assessed for Villalta score and Quality of life changes
- 3 months
- 6 months
- 9 months
MUFFIN Study Coordinator:
Elena Shulikovsky
TEL: 514-340-8222 ext. 23703
